Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01073267 · ClinicalTrials.gov registry record · Phase 2

Study of Total Skin Electron Beam Therapy (TSEBT) in Stage IB-IIIA Mycosis Fungoides

A Phase 2 study, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
Phase 2
Development phase
4
Enrollment target

NCT01073267: Completed Phase 2 study, sponsored by M.D. Anderson Cancer Center.

NCT01073267 is a Phase 2 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 4 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01073267, a Phase 2 study, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
Phase 2
Development phase
4 participants
Enrollment target

Study Summary

The goal of this clinical research study is to learn if a lower than standard dose of total skin electron beam radiation therapy to the skin can help to control mycosis fungoides. The safety of this dose level will also be studied.

Primary Outcome

Objective response rate defined as the proportion of participants achieving complete clinical response (CCR) and partial response (PR) (i.e. overall response (OR)) as assessed by the modified Severity-Weighted Assessment Tool (mSWAT). Clinical response (according to mSWAT) are documented as stable disease (SD), partial response (PR), complete clinical response (CCR), or progressive disease (PD) as defined: Complete clinical response (CCR): no evidence of cutaneous disease on exam, confirmed at

Interventions

  • RADIATION TSEBT

Trial Details

FieldValue
Enrollment Target 4 participants
Start Date 2010-02
Est. Completion 2014-12
Phase Phase 2
M.D. Anderson Cancer Center

2,692 total trials

What the finished NCT01073267 record still lists

NCT01073267 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 1 intervention - of which TSEBT is the first listed.

NCT01073267 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01073267 about?

NCT01073267 is a clinical study titled "Study of Total Skin Electron Beam Therapy (TSEBT) in Stage IB-IIIA Mycosis Fungoides". The goal of this clinical research study is to learn if a lower than standard dose of total skin electron beam radiation therapy to the skin can help to control mycosis fungoides. The safety of this dose level will also be studied.

What is the current status of trial NCT01073267?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2010-02. Estimated completion is 2014-12.

What interventions are being tested in trial NCT01073267?

The interventions under investigation include: TSEBT (RADIATION).

Who is sponsoring clinical trial NCT01073267?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01073267's enrollment target sits among peer trials

4 2001st of 2000 the lowest of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01073267, the US trial registry maintained by the National Library of Medicine. NCT01073267 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.